Ms. Hetrick serves in AbbVie’s Regulatory Policy function where she attends to evolving regulations and policies governing pharmaceutical development issued by the US FDA. She monitors policies in their formative stages, analyzes their impact on the company, informs executive staff of issues, and helps functional areas within her company understand the impact. Ms. Hetrick has served in a variety of regulatory affairs roles in her career during time spent at FDA, NIH, small biotech, and large pharma. Her current role is one in which she establishes, develops, and maintains relationships with representatives of FDA, the industry trade associations (PhRMA and BIO), and healthcare interest groups regarding policies of importance to AbbVie.